Abstract

Objective Adipose tissue stem cells (ADSCs) present a promising therapeutic method to alleviate liver failure (LF). The purpose of this prospective study was to evaluate the efficacy of undifferentiated ADSC transplantation on liver regeneration and on the expression of liver regeneration- and liver-specific genes, following 60% partial hepatectomy (PHx). Methods Sixty female rats were subjected to PHx and were transplanted with 106 or 2 × 106 ADSCs, either into the portal vein (PV) or into the hepatic parenchyma. Animals of the control group were not transplanted and served as controls. Animals were sacrificed on the 4th, the 7th, or the 15th postoperative day (POD). Results The transplanted ADSCs were successfully engrafted into the liver parenchyma and ameliorated the histopathologic damage on the 7th and 15th POD. All transplanted animals demonstrated a significantly higher liver regeneration rate on the 4th and 7th POD, compared with the control group. The expression of hepatocyte growth factor, α-fetoprotein, tyrosine aminotransferase, hepatocyte nuclear factor 4a, and cytochrome P450 1A2 was significantly upregulated, compared with the control group. Conclusions Although undifferentiated, ADSC transplantation significantly enhanced the liver regeneration process. These findings may be proven clinically valuable, especially in cases of acute LF.

Highlights

  • Liver failure (LF) is one of the leading causes of morbidity and mortality worldwide [1]

  • In the present prospective study, we aimed to investigate the effect of undifferentiated Adipose tissue stem cells (ADSCs) transplantation on liver regeneration, as well as on the expression of liver-specific genes, in a rat model of partial hepatectomy (PHx), in relation to the number and their route of administration

  • The expression of the rat Y chromosome was observed in the liver parenchyma of all transplanted rats of all postoperative day (POD) of sacrifice, irrespective of the number or the route of transplantation, whereas it was not observed in nontransplanted animals, demonstrating the successful transplantation and localization of ADSCs (Figure 5)

Read more

Summary

Introduction

Liver failure (LF) is one of the leading causes of morbidity and mortality worldwide [1]. The only effective treatment so far for acute and chronic LF is liver transplantation [2], with its associated limitations, including the shortage of liver donors and the need for continuous immunosuppression. Number of transplanted ADSCs 4 days Control group

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call